ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 596 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR 8-Year-Old Cancer Survivor Celebrates Recovery By Donating Her Birthday Gifts To... July 23, 2019 Trial Results Support Adding Daratumumab to Initial Treatment for Multiple Myeloma January 19, 2024 Selpercatinib Shows Durable Efficacy in RET-Altered Thyroid Cancer August 28, 2020 ESMO Issues First Recommendations on Using Next-Generation Sequencing for Advanced Cancers... August 24, 2020 Load more HOT NEWS Robust and Durable Clinical Activity of Tepotinib in Patients with METex14-Skipping... FDA Approves BCMA-Targeted CAR T-Cell Therapy for Multiple Myeloma Hyperfractionated Intensity-Modulated Radiotherapy Decreases the Rate of Severe Late Complications and... Frederick National Laboratory for Cancer Research: A Unique Resource for the...
